EXaminaTion of cRitical cAre PHArmacist pRoductivity MetricS (EXTRA-PHARMS): The clinical pharmacist's perspective

IF 1.3 Q4 PHARMACOLOGY & PHARMACY Journal of the American College of Clinical Pharmacy : JACCP Pub Date : 2024-10-30 DOI:10.1002/jac5.2040
Christy Forehand Pharm.D., Russel Roberts Pharm.D., Nicole M. Acquisto Pharm.D., FCCP, Mitchell Buckley Pharm.D., FCCP, Christine M. Groth Pharm.D., Devin Holden Pharm.D., Andrea Sikora Pharm.D., Thomas (Tomi) Ardiles M.D., Melissa Thompson Bastin Pharm.D., Ph.D., Sivasubramanium V. Bhavani M.D., Ashley DePriest M.S., Ifeoma Mary Eche Pharm.D., Brigid Flynn M.D., William J. Healy M.D., Brett Hogan MSN, Brenton LaRiccia M.S., MBA, Kirby Mayer DPT, Ph.D., David Murphy M.D., Ph.D., Lucy Stun Pharm.D., Shan Wang Pharm.D., Nicola Zetola M.D., Robert MacLaren Pharm.D., MPH, FCCP
{"title":"EXaminaTion of cRitical cAre PHArmacist pRoductivity MetricS (EXTRA-PHARMS): The clinical pharmacist's perspective","authors":"Christy Forehand Pharm.D.,&nbsp;Russel Roberts Pharm.D.,&nbsp;Nicole M. Acquisto Pharm.D., FCCP,&nbsp;Mitchell Buckley Pharm.D., FCCP,&nbsp;Christine M. Groth Pharm.D.,&nbsp;Devin Holden Pharm.D.,&nbsp;Andrea Sikora Pharm.D.,&nbsp;Thomas (Tomi) Ardiles M.D.,&nbsp;Melissa Thompson Bastin Pharm.D., Ph.D.,&nbsp;Sivasubramanium V. Bhavani M.D.,&nbsp;Ashley DePriest M.S.,&nbsp;Ifeoma Mary Eche Pharm.D.,&nbsp;Brigid Flynn M.D.,&nbsp;William J. Healy M.D.,&nbsp;Brett Hogan MSN,&nbsp;Brenton LaRiccia M.S., MBA,&nbsp;Kirby Mayer DPT, Ph.D.,&nbsp;David Murphy M.D., Ph.D.,&nbsp;Lucy Stun Pharm.D.,&nbsp;Shan Wang Pharm.D.,&nbsp;Nicola Zetola M.D.,&nbsp;Robert MacLaren Pharm.D., MPH, FCCP","doi":"10.1002/jac5.2040","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Critical care pharmacists are well-established, valuable members of the intensive care unit interprofessional team with unique skills to perform comprehensive medication management in complex critically ill patients. However, standardized and consequential productivity metrics for critical care pharmacists have not been established.</p>\n </section>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>To characterize the utilization and perception of contemporary critical care pharmacy productivity metrics utilized among individual institutions.</p>\n </section>\n \n <section>\n \n <h3> Design, Setting, and Participants</h3>\n \n <p>An electronic survey was distributed to critical care pharmacist members of the Society of Critical Care Medicine Clinical Pharmacy and Pharmacology Section and the American College of Clinical Pharmacy Critical Care Practice and Research Network.</p>\n </section>\n \n <section>\n \n <h3> Main Outcomes and Measures</h3>\n \n <p>The survey included 23 questions to assess institution demographics, individual respondent demographics, institution practices, and individual respondent perceptions about the value of critical care pharmacist productivity metrics.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 204 critical care pharmacists, largely from the United States, responded to the survey between July and November 2022. Institutional metrics captured by more than 50% of the respondents' institutions included order verification rate/number of orders verified (60%), number of clinical interventions (57%), and intravenous to enteral product interchanges (52%). Of these metrics, critical care pharmacists only agreed with the value of the number of clinical interventions, were indifferent to the value of intravenous to oral product interchanges, and disagreed with the value of order verification rate/number of orders verified.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Significant discrepancies exist between institutional productivity metric practices and their perceived value and utility among critical care pharmacists.</p>\n </section>\n </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 11","pages":"1084-1093"},"PeriodicalIF":1.3000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Clinical Pharmacy : JACCP","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jac5.2040","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Critical care pharmacists are well-established, valuable members of the intensive care unit interprofessional team with unique skills to perform comprehensive medication management in complex critically ill patients. However, standardized and consequential productivity metrics for critical care pharmacists have not been established.

Objective

To characterize the utilization and perception of contemporary critical care pharmacy productivity metrics utilized among individual institutions.

Design, Setting, and Participants

An electronic survey was distributed to critical care pharmacist members of the Society of Critical Care Medicine Clinical Pharmacy and Pharmacology Section and the American College of Clinical Pharmacy Critical Care Practice and Research Network.

Main Outcomes and Measures

The survey included 23 questions to assess institution demographics, individual respondent demographics, institution practices, and individual respondent perceptions about the value of critical care pharmacist productivity metrics.

Results

A total of 204 critical care pharmacists, largely from the United States, responded to the survey between July and November 2022. Institutional metrics captured by more than 50% of the respondents' institutions included order verification rate/number of orders verified (60%), number of clinical interventions (57%), and intravenous to enteral product interchanges (52%). Of these metrics, critical care pharmacists only agreed with the value of the number of clinical interventions, were indifferent to the value of intravenous to oral product interchanges, and disagreed with the value of order verification rate/number of orders verified.

Conclusions

Significant discrepancies exist between institutional productivity metric practices and their perceived value and utility among critical care pharmacists.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对临床药师药效指标(EXTRA-PHARMS)的研究:临床药师的视角
背景 重症监护药剂师是重症监护病房跨专业团队中公认的宝贵成员,拥有为复杂重症患者进行全面药物管理的独特技能。然而,针对重症监护药剂师的标准化和相应的生产力指标尚未建立。 目的 了解各个机构对当代重症监护药剂师工作效率指标的使用情况和看法。 设计、设置和参与者 向重症医学会临床药学和药理学分会以及美国临床药学院重症监护实践和研究网络的重症监护药剂师成员发放了一份电子调查问卷。 主要结果和测量方法 调查包括 23 个问题,用于评估机构人口统计学、受访者个人人口统计学、机构实践以及受访者个人对重症监护药剂师生产力指标价值的看法。 结果 在 2022 年 7 月至 11 月期间,共有 204 名重症监护药剂师对调查做出了回复,其中大部分来自美国。50%以上的受访者所在机构采用的机构指标包括医嘱验证率/已验证医嘱数量(60%)、临床干预次数(57%)和静脉注射与肠内产品交换次数(52%)。在这些指标中,重症监护药剂师只同意临床干预次数的价值,对静脉注射与口服产品交换的价值无动于衷,不同意医嘱核查率/已核查医嘱数量的价值。 结论 重症监护药剂师对机构生产率指标的实践与其认为的价值和效用之间存在显著差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.70
自引率
0.00%
发文量
0
期刊最新文献
Issue Information Teaching experiences in pharmacy residency Comment on “Pharmacists should be held to high standards, not hindered by bright-line rules” Not just a collection of papers Issue Information
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1